Börner H, Teichmann G
Z Gesamte Inn Med. 1978 Jan 15;33(2):44-8.
On account of the complex effective mechanism the control of dihydralazin is performed particularly with regard to the changes of the plasma-renin-activity. The examinations were carried out in 7 patients each with renal and essential hypertension. The plasma-renin-activity, the behaviour of blood pressure, the stroke volume and the minute volume as well as the peripheral arterial resistance should be examined concerning the influence of two doses of dihydralazin and with regard to the influence of the basic disease to the above mentioned parameters. The plasma-renin-activity is decreased as well as increased by dihydralazin. Baroreceptors are made responsible for the renin regulation. Already with 4.125 mg dihydralazin (1/8 ampoule Depressan) nearly the same permanent effect reducing the blood pressure is to be achieved as with a double dosage. Stroke volume and minute volume are reduced by dihydralazin. The peripheral arterial resistance decreases in no case, but in the renal hypertension it shows a rising tendency. With the help of these examinations it shall particularly referred to the fact that the therapeutic mechanism of the slowly beginning and long lasting decrease of blood pressure is not yet be fully clarified.
由于双肼屈嗪的作用机制复杂,其控制尤其要考虑血浆肾素活性的变化。对7例肾性高血压患者和7例原发性高血压患者进行了检查。应就两剂双肼屈嗪的影响以及基础疾病对上述参数的影响,检查血浆肾素活性、血压变化、每搏输出量和每分钟心输出量以及外周动脉阻力。双肼屈嗪可降低也可增加血浆肾素活性。压力感受器负责肾素调节。使用4.125毫克双肼屈嗪(1/8支降压嗪)时,就能达到与双倍剂量几乎相同的持续降压效果。双肼屈嗪可降低每搏输出量和每分钟心输出量。外周动脉阻力在任何情况下均不会降低,但在肾性高血压中呈上升趋势。借助这些检查应特别指出,血压缓慢开始并持续下降的治疗机制尚未完全阐明。